HWM
PTCT icon

Hemington Wealth Management’s PTC Therapeutics PTCT Stock Holding History

Hemington Wealth Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6K Buy
98
+11
+13% +$573 ﹤0.01% 1075
2025
Q2 		$4K Sell
87
-4
-4% -$190 ﹤0.01% 1182
2025
Q1 		$4K Buy
91
+39
+75% +$1.95K ﹤0.01% 1140
2024
Q4 		$2K Buy
52
+29
+126% +$1.24K ﹤0.01% 1311
2024
Q3 		$0 Buy
+23
New +$770 ﹤0.01% 1692

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hemington Wealth Management's PTCT Position: Q3 2025 in Review

Hemington Wealth Management increased its PTC Therapeutics (PTCT) stake by 13% in Q3 2025, buying an estimated $573 and bringing the position to 98 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Hemington Wealth Management first reported a position in PTCT in Q3 2024 and has held it in 5 quarters since. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • Hemington Wealth Management held 98 shares of PTC Therapeutics worth $6K as of Q3 2025.
  • Hemington Wealth Management bought 11 PTC Therapeutics shares in Q3 2025, an estimated $573.
  • PTC Therapeutics made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1075 holding.
  • Hemington Wealth Management first reported a position in PTC Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.